About Careers Internship MedBlog Contact us

Breast Cancer Risk In Menopausal Women Can Be Reduced By Hormone Mix

by Aruna on October 23, 2009 at 9:35 AM
Breast Cancer Risk In Menopausal Women Can Be Reduced By Hormone Mix

Researchers say a right mix of estrogen and a selective estrogen receptor modulator (SERM) can significantly reduce breast cancer risk in menopausal women.

Selective estrogen receptor modulator (SERM) blocks the effects of estrogen in breast tissue.


Women in menopause who have symptoms are currently treated with a combination of estrogen plus progestin hormone therapy, however this treatment comes with side effects, including a higher risk of breast cancer caused by the progestin.

Yale researchers sought to determine a better way of administering hormone therapy without the breast cancer risk.

During the study, lead researcher Dr Hugh S. Taylor, professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale, and his colleagues treated breast and endometrial cell lines with either estrogen or estrogen plus one of the SERMs.

They later looked at various markers of cell growth, including proliferating cell nuclear antigen (PCNA), one of the best-characterized markers of cell growth.

The team found that PCNA was increased when they stimulated cells with estrogen and decreased when they added a SERM, indicating that the SERM blocked cell growth.

Taylor said that breast and uterine cells won't be stimulated by the estrogen plus SERM combination, so women in menopause get the benefits of estrogen without the risk of progestin.

Progestin is a double-edged sword, Taylor said. It poses a breast cancer risk, but if you use estrogen alone without progestin, there is a higher risk of uterine cancer. Therefore SERMs appear to be a good substitute for progestin.

"In our study, the right combination of estrogen and various SERMs was able to prevent the proliferation of breast and endometrial cells," said Taylor.

"These preliminary findings could lead to a better way of administering hormone therapy to women in menopause," he added.

The findings were presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia.

Source: ANI
Font : A-A+



Recommended Readings

Latest Women Health News

Why Women Participate Less in Cardiovascular Rehabilitation?
Cardiovascular rehabilitation, which lowers mortality and readmission rates, is underutilized and less effective in women than in men.
Wearable Optical Device Helps Early Detection of Postpartum Hemorrhage
Laser speckle wearable gadget helps in the early detection of postpartum hemorrhage, potentially reducing maternal mortality rates.
Placenta Unravels Anonymous Miscarriages & Stillbirths
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Predictive Tools for Pregnancy Complications Related to Fetal Growth
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
Urine Ovulation Test may Raise your Chances of Pregnancy
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Breast Cancer Risk In Menopausal Women Can Be Reduced By Hormone Mix Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests